Neo Medical, developer of spinal fusion devices, acquired Germany-based TriOs Medical. Neo is leveraging years of collaboration with TriOs as the company's exclusive commercialization partner in the region to strengthen its position in the thoracolumbar fixation market.
Since launch of Neo's first product in Germany in 2Q17, the company's products have been used in over 10,000 surgeries, with over 90% of cases performed by recurrent users.
Neo Medical has also appointed a President to lead the company's U.S. operations. Jon P. Verbiest previously worked for 18 years at Synthes Spine and Depuy Synthes before joining K2M, Spine Wave, Silony Medical and H Wave in Director of Sales and Business Development roles in the U.S.
Vincent Lefauconnier, Neo Medical CEO, said, "With a 45% growth in 2020, Neo Medical remains on its rapid development trajectory despite the current health and economic context. This year will continue to see the company accelerating in our two strategic markets, Germany and the U.S., starting with the milestones announced today, "while growing rapidly in the other European regions where we currently operate.